Broad phenotypic spectrum of germ line 7p12.1 microdeletions encompassing the IKZF1 gene includes predisposition to acute lymphoblastic leukemia.


Journal

Genes, chromosomes & cancer
ISSN: 1098-2264
Titre abrégé: Genes Chromosomes Cancer
Pays: United States
ID NLM: 9007329

Informations de publication

Date de publication:
02 2021
Historique:
received: 12 07 2020
revised: 29 10 2020
accepted: 30 10 2020
pubmed: 3 11 2020
medline: 12 1 2022
entrez: 2 11 2020
Statut: ppublish

Résumé

Microdeletions of 7p12.1 encompassing the IKZF1 gene locus are rare, with few cases reported. The common phenotype includes intellectual disability, overgrowth, and facial dysmorphism accompanied, albeit rarely, by congenital anomalies. Haploinsufficiency of IKZF1 predisposes individuals to childhood acute lymphoblastic leukemia (ALL). In this study, we comprehensively analyzed the frequency of 7p12.1 deletions among 4581 Polish individuals who underwent chromosomal microarray testing for unexplained developmental delay, intellectual disability, and/or congenital anomalies. Two unrelated individuals (0.04%) with a de novo interstitial 7p12.1 microdeletion encompassing IKZF1 were identified. One developed ALL. Analysis of the incidence and the phenotype of constitutional 7p12.1 microdeletion, which based on the previously annotated patients data in public databases and literature reports, revealed 21 cases including five patients diagnosed with ALL.

Identifiants

pubmed: 33135230
doi: 10.1002/gcc.22914
doi:

Substances chimiques

IKZF1 protein, human 0
Ikaros Transcription Factor 148971-36-2

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-87

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Kuehn HS, Boisson B, Cunningham-Rundles C, et al. Loss of B cells in patients with heterozygous mutations in IKAROS. New Engl J Med. 2016;374(11):1032-1043.
Mendoza-Londono R, Kashork CD, Shaffer LG, Krance R, Plon SE. Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes. Genes Chromosomes Cancer. 2005;42(1):82-86.
Järviaho T, Zachariadis V, Tesi B, et al. Microdeletion of 7p12.1p13, including IKZF1, causes intellectual impairment, overgrowth, and susceptibility to leukaemia. Br J Haematol. 2019;185(2):354-357.
Garin I, Rica I, Estalella I, et al. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients. Clin Endocrinol (Oxf). 2008;68(6):873-878.
Schwarzbraun T, Windpassinger C, Ofner L, et al. Genomic analysis of five chromosome 7p deletion patients with Greig cephalopolysyndactyly syndrome (GCPS). Eur J Med Genet. 2006;49(4):338-345.
John LB, Ward AC. The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Molec Immunol. 2011;48(9):1272-1278.
Oravecz A, Apostolov A, Polak K, et al. Ikaros mediates gene silencing in T cells through Polycomb repressive complex 2. Nat Commun. 2015;6(1):8823.
O'Neill DW, Schoetz SS, Lopez RA, et al. An Ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol. 2000;20(20):7572-7582.
Wang J-H, Nichogiannopoulou A, Wu L, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 1996;5(6):537-549.
Nichogiannopoulou A, Trevisan M, Neben S, Friedrich C, Georgopoulos K. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med. 1999;190(9):1201-1214.
Dumortier A, Jeannet R, Kirstetter P, et al. Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol. 2006;26(1):209-220.
Schwickert TA, Tagoh H, Gültekin S, et al. Stage-specific control of early B cell development by the transcription factor Ikaros. Nat Immunol. 2014;15(3):283-293.
Mantha S, Ward M, McCafferty J, et al. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant plastic/+ mice. Leuk Res. 2007;31(3):321-327.
Goldman FD, Gurel Z, Al-Zubeidi D, et al. Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the ikaros gene. Pediatr Blood Cancer. 2012;58(4):591-597.
Hoshino A, Okada S, Yoshida K, et al. Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations. J Allergy Clin Immunol. 2017;140(1):223-231.
Churchman ML, Qian M, te Kronnie G, et al. Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell. 2018;33(5):937-948.e8.
Yoshida N, Sakaguchi H, Muramatsu H, et al. Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia. Leukemia. 2017;31(5):1221-1223.
Treviño LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9):1001-1005.
Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453(7191):110-114.
Iacobucci I, Storlazzi CT, Cilloni D, et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto acute leukemia working party (GIMEMA AL WP). Blood. 2009;114(10):2159-2167.
Dupuis A, Gaub MP, Legrain M, et al. Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia. 2013;27(2):503-507.
Porter CC, Druley TE, Erez A, et al. Recommendations for surveillance for children with leukemia-predisposing conditions. Clin Cancer Res. 2017;23(11):14-22.
Rampersaud E, Ziegler DS, Iacobucci I, et al. Germline deletion of ETV6 in familial acute lymphoblastic leukemia. Blood Adv. 2019;3(7):1039-1046.
López GP, Quispe BV, Cabrejas Núñez MJ, Castaño L, Barrio R. Dysmorphic features, frontal cerebral cavernoma, and hyperglycemia in a girl with a de novo deletion of 7.23 Mb in region 7p13-p12.1. J Clin Res Pediatr Endocrinol. 2017;9(4):355-359.
Reid MM, Summerfield GP. Distinction between aleukaemic prodrome of childhood acute lymphoblastic leukaemia and aplastic anaemia. J Clin Pathol. 1992;45(8):697-700.
Breatnach F, Chessells JM, Greaves MF. The aplastic presentation of childhood leukaemia: a feature of common-ALL. Br J Haematol. 1981;49(3):387-393.

Auteurs

Agata Pastorczak (A)

Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

Anna Hogendorf (A)

Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland.

Zuzanna Urbanska (Z)

Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

Edyta Budzynska (E)

Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.

Dorota Jesionek-Kupnicka (D)

Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland.

Agnieszka Gach (A)

Department of Medical Genetics, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.

Wanda Hawula (W)

Department of Medical Genetics, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.

Robert Smigiel (R)

Department of Pediatrics, Division of Propaedeutic Pediatrics and Rare Disorders, Wroclaw Medical University, Wroclaw, Poland.

Pawel Skiba (P)

Department of Genetics, Wroclaw Medical University, Wroclaw, Poland.

Maria Sasiadek (M)

Department of Genetics, Wroclaw Medical University, Wroclaw, Poland.

Monika Lejman (M)

Laboratory of Genetic Diagnostics, Medical University of Lublin, Lublin, Poland.

Maria Constatinou (M)

Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland.

Beata S Lipska-Ziętkiewicz (BS)

Centre for Rare Diseases, Medical University of Gdansk, Gdansk, Poland.
Clinial Genetics Unit, Department of Biology and Medical Genetics, Medical University of Gdansk, Gdansk, Poland.

Wojciech Mlynarski (W)

Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH